Palomar Holdings enters mid-May under visible analyst pressure — two firms trimmed price targets in the past three days, the stock is down 15% over the past month, and options traders are as bullish as they have been all year even as the share price retreats.
Options positioning is the sharpest signal right now. The put/call ratio has collapsed to 0.17, nearly two standard deviations below its 20-day average of 0.27. That is close to the lowest reading of the past 52 weeks. Far from hedging, options flow has swung emphatically toward calls — an unusual degree of bullish conviction from a market that just watched the stock drop from around $128 to $108.
The Street is still constructive but getting more cautious on valuation. Keefe, Bruyette & Woods maintained its Outperform on Wednesday but cut its target sharply from $186 to $159. Piper Sandler moved in the same direction on Monday, trimming from $151 to $132 while holding its Overweight. Both firms kept their positive ratings — the message is that the thesis remains intact, but the re-rating after the post-earnings pullback forces a lower anchor. The consensus mean target is $159.83, implying roughly 47% upside to the current price of $108.63. That is a wide gap, and it reflects how aggressively the stock has de-rated. The trailing P/E has compressed by about 2.2 points over the past month to 10.6x, and price-to-book has fallen 0.33x over the same period to 2.4x. EPS momentum tells a more constructive story — the 30-day rank is 74th percentile and the 90-day rank is 89th — suggesting forward estimates have held up even as the price has not. The RSI14 sits at 29, firmly in oversold territory.
Short interest is growing but not at an alarming level. SI % of free float has climbed to 2.67%, up from 2.16% at the start of April — a steady rise of around 12.5% over the past week alone. A month ago it was at 2.19%. The build is gradual rather than aggressive, and borrow conditions remain easy. Availability is loose, and cost to borrow is just 0.44% — a fee structure that imposes almost no friction on new shorts. The ORTEX short score of 32.5, roughly the 56th percentile, does not flag extreme positioning in either direction.
Insider activity adds a cautious footnote. Founder and CEO Mac Armstrong sold shares on April 15 and April 21, totalling around $870k across those two dates. President Jon Christianson also sold on April 15. Both sets of sales came at prices between $128 and $132, well above current levels, and the significance scores assigned to these transactions were low — they appear consistent with a plan-based selling programme rather than a directional call. Net insider activity over the past 90 days remains positive at roughly 19,800 net shares, largely reflecting an award of 6,250 shares to Armstrong on April 15.
The most recent earnings print, filed in early May, produced a muted positive reaction — the stock moved up about 1.6% on the day. The bear case centres on earthquake GWP growth stalling and the core loss ratio coming in above expectations; the bull case is that pricing improvements will eventually flow through into margins and EPS, with forward estimates for 2026 and 2027 still pointing higher. What to watch now is whether the gap between the consensus price target and the current price narrows through estimate revisions or a price recovery — and whether the unusually bullish options positioning from this week proves prescient or premature.
See the live data behind this article on ORTEX.
Open PLMR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
